All In MedTech

FDA Clearance Tracker · P230043

Multi-Target Stool DNA (mtsDNA) Test, Cologuard Plus™

Premarket approval (PMA) is the pathway for the highest-risk devices. FDA reviews clinical evidence of safety and effectiveness before approving.

Last checked: Nov 19, 2026Latest source record: Oct 3, 2024 (this decision)Source: openFDAMethods & limitations

PMA

Decided

Oct 3, 2024

Approved

Time to decision

286 days

Received Dec 22, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA

Device class

Class III

The decision

FDA number
P230043
Device name
Multi-Target Stool DNA (mtsDNA) Test, Cologuard Plus™
Applicant location
Madision, WI
Received
Dec 22, 2023
Decided
Oct 3, 2024
Decision
Approved
Supplements
10 in FDA's data for this PMA. See them on the FDA record

Device type

Device class
Class III

Every decision under product code PHP

FDA's approval statement

As written in FDA's record.

A qualitative in vitro diagnostic test intended for the detection of colorectal neoplasia-associated DNA markers and for the presence of occult hemoglobin in human stool. The Cologuard Plus test is performed on samples collected using the Cologuard Plus Collection Kit. A positive result may indicate the presence of colorectal cancer (CRC) or advance precancerous lesions (APL) and should be followed by a colonoscopy. The Cologuard Plus test is indicated to screen adults 45 years or older who are at average risk for CRC. The Cologuard Plus test is not a replacement for diagnostic colonoscopy in high-risk individuals. The Cologuard Plus test is performed at Exact Sciences, Madison, WI.

How new is this?

These are facts about FDA's records. They are not a judgment about the device.

  • It is not the first decision under product code PHP. The earliest in FDA's data is P130017, decided Aug 11, 2014.
  • It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.

Source documents

Other decisions for Exact Sciences Corporation

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.